Page 37 - MemoriaBBN-Eng

www.ciber-bbn.es

This platform provides biological molecules which are currently peptide and pro-
Purpose and
functionality
tein in nature and necessary for carrying projects relating to the strategic lines
of Devices, Implants, Regenerative Medicine, and especially Nanoconjugates and

Biosensors. They offer services for the customized design and production of these

elements for:

• Functionalizing nanosystems

• Functionalizing implants and prostheses

• Providing essential elements in regenerative and angiogenic processes

• Functionalizing surfaces

PLATFORM OF PRODUCTION OF BIOMATERIALS AND
NANOPARTICLES

• Biodeposition and biodetection
Units
• Rapid prototyping

•
Molecular biomaterial processing and nanostructuring

• Nanolithography / E-beam

• Micro/naoelectronics

• Nanoparticle synthesis

• Drug formulation (new incorporation)

To advise and provide materials for correctly carrying out projects requiring them,
General Objective
keeping activity outside the research activity of the coordinating group and provi-

de external high value-added services, taking advantage of the experience of the
groups to provide solutions to technological problem solving.

This platform provides both 2D and 3D materials and constructions that provide
Purpose and
functionality
support to projects primarily comprised in the Bioengineering Programme, spe-
cifically in the lines of Implants and Regenerative Medicine, and in the line of

Nanomedicine, especially in Nanoconjugates. It provides services for:

• Functionalizing devices and biosensors by means of solution dispensing.

•
Surface treatments to favour integration; coating implants and prostheses
with bioactive factors.
13
• Creating 3D matrices with materials such as polymers, ceramics and compo- 20
T
sites; preparing scaffolds or prototypes for testing; or even functionalizing by OR
P
adding stem cells.
RE
L
• Production and characterization of pure nanometric-sized drug substances, A
vesicular systems, nanosuspensions or compounds formed by a biocompatible NU
N
polymer and a drug substance.
A
N /
• Synthesis of particles and functionalized surfaces.
B
-B
• Pilot-scale preparation and characterization of molecular materials with a con- R
BE
trolled micro-nano- and supramolecular structure with different functionalities.
CI

37